Nike gets an upgrade from KeyBanc as turnaround materializes

KeyBanc upgraded Nike to overweight from sector weight with a $90 price target, implying over 21% upside, following the company's fiscal first-quarter earnings and revenue beat. The bank anticipates a "sustainable recovery" driven by Nike's "Win Now" actions, innovation pipeline, and strong running business growth exceeding 20%, despite near-term headwinds like tariffs and a potential sluggish holiday season. While shares jumped 6% post-earnings, they remain down nearly 2% year-to-date, contrasting with the S&P 500's advance.

Analysis

Nike's (NKE) fiscal first-quarter earnings and revenue beat has prompted a bullish revision from KeyBanc, which upgraded the stock to overweight with a $90 price target, implying over 21% upside. The bank's thesis centers on a "sustainable recovery" driven by strategic "Win Now" actions and a refreshed innovation pipeline, with tangible evidence seen in the running business, which posted strong growth exceeding 20% in the quarter. However, significant headwinds persist, including a company-issued warning of a sluggish holiday season and acknowledged near-term choppiness from tariffs and challenges in China. Despite a 6% share price jump following the report, NKE remains down nearly 2% year-to-date, starkly underperforming the S&P 500's 14% advance and facing a potential fourth consecutive annual decline amidst rising competition. This fundamental uncertainty is reflected in the analyst community, which LSEG data shows is almost evenly split between buy ratings (20) and hold/underperform ratings (19), highlighting a lack of consensus on whether recent operational improvements can overcome the documented macroeconomic and competitive pressures.

Key Decisions for Investors

• Investors bullish on the turnaround thesis could view the recent earnings beat and 20%+ growth in the running segment as a potential entry point, aligning with KeyBanc's 'sustainable recovery' outlook.
• It is prudent to closely monitor upcoming holiday sales figures and management commentary on China and tariffs, as these have been explicitly identified as primary near-term risks that could challenge the recovery narrative.
• Given the stock's significant multi-year underperformance and the divided analyst community, investors should weigh the potential turnaround against the risk of continued lagging returns and intensifying competition from brands like Hoka.
• The success of the new product introduction cycle, with one major running footwear style planned per season, should be tracked as a critical catalyst for confirming sustained growth and margin recovery.